Previous 10 | Next 10 |
A federal appeals court has ruled in Eli Lilly's ( LLY +0.9% ) favor, upholding an October 2017 decision by the USPTO's Patent Trial and Appeal Board that its patent covering a vitamin regimen for lung cancer med Alimta (pemetrexed) is valid. More news on: Eli Lilly and Company, Novart...
The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval for Mylan's ( MYL +0.4% ) ambrisentan, a generic version of GlaxoSmithKline's ( GSK +0.3% ) pulmonary arterial hypertension med Volibris . More news on: Mylan N.V., Gilead Scienc...
HERTFORDSHIRE, England , and PITTSBURGH , April 26, 2019 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it will release its first quarter 2019 financial results on Tues., May 7 , before the open of the U.S. financial markets. The company al...
Source: BigCharts Long-suffering shareholders have seemingly thrown in the towel on Adamis ( ADMP ) - again! When will they ever learn? Just over the past year, ADMP has fallen and rebounded many times (see my earlier article) . Interestingly, the stock penetrated a lower technical suppor...
Mylan N.V. (NASDAQ: MYL ) will collaborate with non-profit drug developer TB Alliance to advance a new drug called pretomanid in two combination regimens to treat tuberculosis (TB). More news on: Mylan N.V., Healthcare stocks news, Read more ...
NEW YORK and HERTFORDSHIRE, England and PITTSBURGH , April 18, 2019 /PRNewswire/ -- Non-profit drug developer, TB Alliance, and pharmaceutical company, Mylan N.V. (NASDAQ: MYL), today announced a global collaboration to make the experimental drug pretomanid accessible...
Lannett Company ( LCI -3.8% ) slips on below-average volume on the heels of an article on Seeking Alpha by The Capitolist about an investigation into price collusion by the Connecticut AG's office. More news on: Lannett Company, Inc., Teva Pharmaceutical Industries Limited, Mylan N.V.,...
The investigation into generic drug price fixing has been picking up steam, the equity analysts refuse to recognize the potential fines in their models. According to this article in the Hartford Courant: 16 companies and 300 drugs are under investigation for what assistant attorney general a...
AbbVie ( ABBV ) was able to obtain its first approval for SKYRIZI (risankizumab) in Japan for treating patients with psoriasis. This is good news, but the market opportunity in Japan is not better than that of the United States or Europe. It won't be long for potential U.S. approval at all...
I loaded up on shares of drug giant Teva Pharmaceutical (TEVA) over a year ago, and while the share price performance has disappointed, the business results have not. Debt was reduced to plan, headcount has been slashed, plants closed, a reorganization effected, and the drug portfolio thorough...
News, Short Squeeze, Breakout and More Instantly...
Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc. PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Nov. 6, 2020 HERTFORDSHIRE, England and PITTSBURGH , Nov. 6, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ...
Our experts issued a rare "Double Down" Buy alert on this one stock... Learn more. A long-awaited deal will soon be done. Pfizer (NYSE: PFE) and Mylan (NASDAQ: MYL) announced last week that the U.S. Federal Trade Commission has approved the planned merger of Pfizer's...
Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for Viatris PR Newswire HERTFORDSHIRE, England, and PITTSBURGH, Nov. 2, 2020 HERTFORDSHIRE , England, and PITTSBURGH, Nov. 2, 2020 /PRNews...